
Jean (Abou Yared) Yared MD
Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology, Sickle Cell & Other Anemias
Associate Professor of Medicine, Blood and Marrow Transplantation Program, University of Maryland School of Medicine
Join to View Full Profile
22 S Greene St, Room N9E12Univ. Of Md, Marlene & Stewart Greenebaum Cancer CenterBaltimore, MD 21201
Phone+1 410-328-1230
Fax+1 410-328-1975
Dr. Yared is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of MarylandFellowship, Hematology and Medical Oncology, 2010 - 2013
- Greater Baltimore Medical CenterResidency, Internal Medicine, 2007 - 2010
- St Joseph's University Medical SchoolClass of 2002
Certifications & Licensure
- NH State Medical License 2013 - Present
- MD State Medical License 2013 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Clinical Trials
- 1630GCC: Zydelig Maintenance in B-Cell Non-Hodgkin's Lymphoma After Autologous Stem Cell Transplantation Start of enrollment: 2017 Oct 23
Publications & Presentations
PubMed
- 3 citationsOutcomes among adult recipients of CAR T-cell therapy for Burkitt lymphoma.Laura Samples, Hossein Sadrzadeh, Matthew J Frigault, Caron A Jacobson, Mehdi Hamadani
Blood. 2025-06-05 - Efficacy of Total-Body Irradiation-based Intensified Myeloablative Regimens for Acute Leukemia-An International Collaborative Study.Yasuyuki Arai, Ruta Brazauskas, Naya He, A Samer Al-Homsi, Saurabh Chhabra
Ejhaem. 2025-06-01 - 1 citationsCD19 CAR-T With Axicabtagene Ciloleucel in R/R Large B-Cell Lymphoma With/Without Prior Autologous Stem Cell Transplant.David T Chen, Olga Goloubeva, Aaron P Rapoport, Saurabh Dahiya, Djordje Atanackovic
Clinical Lymphoma, Myeloma & Leukemia. 2025-06-01
Abstracts/Posters
- Increased Cortical Glycolysis Following CD19 CART Therapy: A Radiographic Surrogate for an Altered Blood-Brain BarrierJean A. Yared, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) after CD19-Directed Chimeric Antigen Receptor T-Cell Therapy (CAR-T) for Large B-Cell Lymphoma: Predicti...Jean A. Yared, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Other Languages
- French, Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: